Sterilizing the Future of European Surgery

European surgical surges push the chemical gas sterilizer market to 1.71 billion dollars, forcing upgrades to protect delicate robotic tools

28 May 2026

European healthcare facilities are turning to low-temperature chemical gas sterilization to accommodate a surge in complex surgeries. The transition is reshaping the medical equipment sector, lifting the global chemical gas sterilizer market to a $1.71 billion valuation.

The shift is driven by the growing use of delicate, heat-sensitive robotic and endoscopic instruments. Traditional steam autoclaves, which rely on high temperatures, risk damaging the intricate components of these modern surgical tools.

To address this, hospital networks are adopting single-chamber systems that combine sterilization and aeration in a single automated cycle. This integrated approach cuts total gas consumption and eliminates the need to move off-gassing equipment between units, reducing the risk of chemical exposure for healthcare workers.

For regional medical centers, shorter cycle times reduce instrument turnaround delays, allowing for higher patient throughput. The technology also extends the lifespan of specialized tools, offering long-term savings that help offset initial procurement costs. Industry suppliers STERIS and Getinge are expanding their low-temperature portfolios to capture this growing European demand.

However, adoption requires balancing operational advantages against significant upfront capital expenditures. Furthermore, strict European regulatory frameworks mandate continuous validation monitoring and extensive safety training for clinical technicians.

Despite these financial and regulatory hurdles, adoption momentum persists. Hospital administrators are increasingly upgrading their infrastructure ahead of anticipated environmental mandates, centering their long-term strategies on automated chemical gas solutions.